Category: Vaccine Headlines
US Faces $7.8 Billion Measles Risk as Vaccination Rates Decline, Study Finds
Bloomberg A sustained drop in childhood vaccinations could cost the US about $7.8 billion in measles outbreaks over five years, a new study found. The warning comes as vaccine policy and public confidence face fresh pressure under the second Trump administration. Health Secretary Robert F. Kennedy Jr. has moved to reshape a key federal vaccine advisory panel, raising concerns among public […]
Apr 15, 2026
More Americans doubt vaccine safety than trust it
Politico Vaccine skepticism among Americans is widespread, The POLITICO Poll found, indicating that one of Health Secretary Robert F. Kennedy Jr.’s animating priorities is gaining traction. Results from the March poll of 3,851 U.S. adults conducted by Public First show that a plurality of Americans question the safety of vaccines, support reducing the number administered and […]
Apr 15, 2026
Johns Hopkins Scientists Develop Nasal DNA Vaccine for Tuberculosis
Sci Tech Daily A new experimental vaccine takes aim at one of tuberculosis’s most stubborn defenses: the ability of bacteria to persist despite treatment. In a study published in the Journal of Clinical Investigation, researchers from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health report developing a therapeutic DNA vaccine delivered through the nose for tuberculosis (TB). The […]
Apr 8, 2026
Johns Hopkins Team Develops Therapeutic, Nasally Delivered DNA Vaccine for Tuberculosis
Newswise In a paper published today in the Journal of Clinical Investigation, a research team at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health reports developing a therapeutic intranasal (nose-delivered) DNA vaccine against tuberculosis (TB) that fuses two genes with the goal of directing the immune system to fight drug-tolerant bacterial “persisters” […]
Apr 1, 2026
Valneva CEO on Pfizer-partnered Lyme vaccine: Why a phase 3 miss doesn’t tell the whole story
Fierce Biotech In the world of clinical trials, missing the primary endpoint of a pivotal trial typically spells real trouble for a drug program. But for Valneva CEO Thomas Lingelbach, the regulatory future of the company’s Pfizer-partnered Lyme disease vaccine, VLA15, is very much “a matter of negotiation.” “It’s a matter of bringing all the […]
Apr 1, 2026
US left without functioning vaccine panel as adviser says ‘drama distracts’
The Guardian Move comes after judge voided Kennedy’s ACIP picks, leaving key flu, Covid and RSV vaccines in limbo. Amid upheaval to the US vaccine advisory committee Robert Malone, the former co-chair and controversial figure who has opposed vaccines, says he has been pushed out and will not be involved in any future decisions. The move comes […]
Mar 25, 2026
Phase III TB vaccines and MDR-TB treatments
Clinical Trials Arena GlobalData epidemiologists project TB cases across the 16 major markets to reach 4.5 million by 2033. It has been several years since a new tuberculosis (TB) drug advanced into Phase III trials, but momentum in the field is now picking up, with a vaccine and two novel treatments progressing through late-stage studies. […]
Mar 25, 2026
Scientists Can Finally Explain Rare Blood Clots Linked to COVID Vaccines
Science Alert COVID vaccines saved millions of lives, but months into the rollout, a small number of people began developing dangerous blood clots in unusual parts of the body. These only happened after vaccines that used a modified adenovirus to deliver their payload, such as the AstraZeneca vaccine. Why these blood clots formed was a […]
Mar 11, 2026
RFK Jr.’s advisers had a plan to target covid shots. Then it fell apart.
Washington Post Some members of the CDC’s vaccine advisory panel have publicly questioned the safety and manufacturing of the shots, including raising a debunked theory that DNA contaminants in the vaccines are harmful. A key federal vaccine advisory panel has abandoned an attack on the covid-19 mRNA vaccines — a shift that comes as some […]
Mar 11, 2026
Universal flu vaccine: How scientists are closing in on the virus’s ‘weak spots’
BBC While current flu shots need to be updated each season, scientists are finding new ways to make vaccine that could last much longer and cover more strains. Each year, roughly a billion people around the world catch the flu. You’ll know if you’ve got it – it can knock you out for a week or […]
Mar 4, 2026